Squarepoint Ops LLC Has $67,000 Holdings in Waldencast plc (NASDAQ:WALD)

Squarepoint Ops LLC cut its stake in Waldencast plc (NASDAQ:WALD) by 82.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 16,600 shares of the company’s stock after selling 78,847 shares during the quarter. Squarepoint Ops LLC’s holdings in Waldencast were worth $67,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Stonebrook Private Inc. acquired a new position in shares of Waldencast during the 4th quarter worth about $48,000. Ethic Inc. acquired a new position in shares of Waldencast during the 4th quarter worth about $56,000. Northern Trust Corp boosted its stake in shares of Waldencast by 4.1% during the 4th quarter. Northern Trust Corp now owns 167,662 shares of the company’s stock worth $674,000 after buying an additional 6,640 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Waldencast during the 4th quarter worth about $70,000. Finally, Barclays PLC boosted its stake in shares of Waldencast by 15.1% during the 4th quarter. Barclays PLC now owns 37,342 shares of the company’s stock worth $150,000 after buying an additional 4,906 shares during the last quarter. 41.97% of the stock is owned by institutional investors and hedge funds.

Waldencast Stock Down 0.9%

WALD opened at $2.30 on Wednesday. Waldencast plc has a 1-year low of $1.98 and a 1-year high of $4.74. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. The company has a fifty day moving average price of $2.56 and a two-hundred day moving average price of $3.06.

Analyst Upgrades and Downgrades

WALD has been the subject of several recent analyst reports. Canaccord Genuity Group cut their target price on shares of Waldencast from $6.00 to $5.00 and set a “buy” rating for the company in a research note on Thursday, May 15th. DA Davidson reiterated a “buy” rating and issued a $7.50 target price on shares of Waldencast in a research note on Wednesday, March 19th. Telsey Advisory Group cut their target price on shares of Waldencast from $5.00 to $4.00 and set an “outperform” rating for the company in a research note on Thursday, May 15th. Alliance Global Partners reiterated a “buy” rating on shares of Waldencast in a research note on Thursday, May 15th. Finally, Industrial Alliance Securities set a $5.00 target price on shares of Waldencast in a research note on Tuesday, April 22nd. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Waldencast currently has an average rating of “Moderate Buy” and an average price target of $5.11.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.